Production (Stage)
InnoCan Pharma Corporation
INNPF
$0.114
-$0.007-5.79%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -410.53% | 60.69% | -186.05% | 119.07% | -100.11% |
| Total Depreciation and Amortization | 66.67% | -33.33% | -10.00% | 0.00% | 25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 306.53% | -201.83% | 3,253.85% | -99.08% | 1,091.61% |
| Change in Net Operating Assets | -52.08% | 104.15% | -467.62% | 177.21% | -39.25% |
| Cash from Operations | 173.02% | 49.75% | -248.59% | 190.36% | 43.02% |
| Capital Expenditure | -25.00% | 33.33% | -100.00% | -50.00% | 77.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.55% | -- | -- | -- | -- |
| Cash from Investing | -106.15% | 1,183.33% | -100.00% | -50.00% | 77.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.33% | 0.00% | -20.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 5.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.95% | 12.55% | -- | -100.00% | 55.10% |
| Cash from Financing | 149.00% | -53.43% | 17,280.00% | -100.34% | 29.70% |
| Foreign Exchange rate Adjustments | 70.00% | -155.56% | 124.66% | -911.11% | -85.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,869.39% | 62.88% | -122.22% | -16.34% | 610.79% |